Stanford's Virtual Biotech turns 37,000 AI agents into a drug-discovery factory

This demonstrates a major AI-driven advancement in medical research, potentially accelerating drug discovery and reducing healthcare burdens.

Auto-scored: The use of AI agents for drug discovery is a beneficial application with low risk and high mitigation value.